Related Experiment Video
Updated: Sep 1, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 26, 2016
Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy
A N Vgontzas1, T C Friedman, G P Chrousos
1Department of Psychiatry, Pennsylvania State University, Hershey 17033, USA.
Abstract:
We measured morning plasma concentrations of delta sleep-inducing-peptide-like-immunoreactivity (DSIP-LI) in 9 sleep apnea patients, 10 narcolepsy patients, and 11 normal controls. Comparisons between the three groups showed no significant differences, although there was a trend toward association with low levels of DSIP-LI in the narcoleptic group, particularly in patients not using medications. No differences were found in the morning or evening plasma DSIP-LI levels in a second group of 11 normal controls and 8 sleep apneics. Our findings do not appear to support a biological marker role of disease activity for single measures of plasma DSIP in sleep apnea.
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Narcolepsy

